Spontaneous fleroxacin-resistant mutants of Escherichia coli K-i2 were isolated at a frequency of 10-10 to 10-" mutants per CFU plated. All mutants exhibited quinolone-resistant replicative DNA biosynthesis, and 4 of 11 mutants also had decreased amounts of OmpF or OmpC porin. None of the mutants had changes solely in porin proteins.
Fluoroquinolones are synthetic, broad-spectrum antibacterial agents whose primary mechanism of action is the inhibition of DNA gyrase activity (2) . The frequency of resistance to fluoroquinolones in laboratory strains of Escherichia coli is much lower than frequencies for the older related compounds nalidixic and oxolinic acids (13) . Genetic and biochemical analyses of E. coli mutants resistant to norfloxacin have indicated that low-level resistance (4 x MIC) is associated with either decreased outer-membrane permeability or altered DNA gyrase (4) ; high-level resistance is associated with mutations in both permeability and gyrase (5) . The gyrase mutations have been mapped at the gyrA gene, which encodes the A subunit of DNA gyrase, while the pernmeability mutations have been mapped to loci that affect expression of the OmpF porin (13) .
Fleroxacin (Ro 23-6240; AM 833) is a trifluorinated quinolone with an antimicrobial spectrum and potency similar to those of norfloxacin (12) . In the present study, low-level resistance to fleroxacin was examined in a laboratory strain of E. coli K-12 to determine resistance frequency and nature.
Bacterial strains used are listed in Table 1 Antibacterial activity was determined by broth dilution with Antibiotic Medium 3 in 24-well plates (1 ml per well).
An inoculum of 5 x 104 logarithmic-phase cells was used. The MIC was the concentration that inhibited visible growth after 18 h of incubation at 37°C. All Flxr strains exhibited MICs of fleroxacin that were 8-to 10-fold higher than those for the wild-type strain, JF568 ( Table 2) . MICs of norfloxacin and ciprofloxacin were also increased for the mutant strains. MIC increases of ciprofloxacin (4 x to 8 x MIC for wild type) were slightly less than those of fleroxacin, except for strain JSC101. MICs of the ,B-lactams cefoxitin and ceftriaxone for the mutanit strains were similar to those for JF568, except for strains JSC102, JSC103, JSC104, and JSC106. All strains retained the susceptibility of the parent, JF568, to novobiocin and coumermycin, which are inhibitors of the gyrase B subunit (3) .
Susceptibility of the mutant strains of OmpF-or OmpCspecific bacteriophages was determined as an indicator of porin expression. Mid-logarithmic-phase cells (200 ILI) were mixed with 2.0 ml of molten soft agar (0.5% agar) and poured onto the surface of a nutrient agar (1.5% agar) plate. After hardening, 5-,ul aliquots of SM or dilutions of bacteriophage in SM (OmpF-specific K20, OmpC-specific PA2) were spotted directly onto the agar surface and allowed to soak into the agar. The plates were incubated at 37°C, and the PFU were counted after 18 h. The plaquing efficiency was calculated by dividing the number of PFU/ml obtained with the mutant strains by the number of PFU/ml obtained with strain JF568.
Outer-membrane proteins were prepared as described elsewhere (7) . Sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis was performed by using a modification of the procedure of Lundrigan and Earhart (6) Four of the fleroxacin-resistant strains showed reduced plaquing efficiencies in the plaquing assay (Table 3) . Plaquing by K20 (11) was reduced in OmpF-deficient strain JF703 and in strains JSC102, JSC103, JSC104, and JSC106. These strains produced no OmpF protein detectable by SDSpolyacrylamide gel electrophoresis (Fig. 1) . Because plaquing by K20 was only slightly reduced in JSC104, it is possible that this strain has an OmpF protein with altered electrophoretic mobility but little alteration in the K20 attachment site. The OmpC-specific phage PA2 (1) showed reduced plaquing efficiency on control strain JF701 and fleroxacin-resistant strains JSC103 and JSC104; the reportedly OmpC-specific bacteriophage SS4 (11) showed reduced plaquing efficiency only on strain JSC103 (data not shown). Strains JF701, JSC103, and JSC104 lacked or produced only small amounts of the OmpC porin (Fig. 1) . As expected, the four fleroxacinresistant strains with altered outer-membrane properties also showed increased MICs of the ,-lactams cefoxitin and ceftriaxone (Table 2) .
In vitro inhibition of replicative DNA biosynthesis was used as a convenient indicator of DNA gyrase activity (10) . Replicative DNA biosynthesis was measured as ATP-dependent incorporation of [3H]thymidine into trichloroacetic acid-insoluble material in toluene-permeabilized cells of the wild-type and mutant strains (8) (Table 4 ). The 50% incorporation concentrations (IC50s) (concentrations required to reduce ATP-dependent label incorporation by 50%) of quinolones for JF568 and JF703 were similar, indicating that reduced outer-membrane permeability by itself does not affect the assay. All strains isolated as fleroxacin-resistant had IC50s of fleroxacin 3-to 10-fold greater than JF568 had. IC50s of norfloxacin and ciprofloxacin were also greater for these strains, although the size of the increase was generally smaller with ciprofloxacin.
In summary, single-step mutants of E. coli JF568 resistant to low levels of fleroxacin were isolated at a frequency similar to that reported for norfloxacin (10 1-to 10"-1) (4, 5) .
This frequency is 300-fold lower than that reported for the older quinolones, nalidixic and oxolinic acid (13) . In all fleroxacin-resistant strains, replicative DNA biosynthesis, and therefore DNA gyrase activity, was resistant to fluoroquinolones. By phage typing, outer-membrane protein pro- 
